Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer

NCT06509919 · clinicaltrials.gov ↗

RECRUITING

Status

1100

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST: Blood draw

Sponsor

Shanghai Changzheng Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]